Covishield is `safe and immunogenic`, has no side effects, asserts Serum Institute of India
The vaccine candidate, Covishield, is being developed by the UK's Oxford University and US pharma giant AstraZeneca. The SII is a manufacturing partner for the vaccine.
No comments:
Post a Comment